What other stocks do shareholders of (CADX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (CADX) investors own include Albireo Pharma (ALBO) , Agenus (AGEN) , Aeterna Zentaris (AEZS) , Authentidate (ADAT) , Acasti Pharma (ACST) , Axcelis Technologies (ACLS) , Achillion Pharmaceuticals (ACHN) , Atlantic Coast Financial (ACFC) , Acer Therapeutics (ACER) and ARCA biopharma (ABIO) .

NASDAQ:CADX

(CADX) (CADX) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free CADX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (CADX) alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About (CADX) Stock (NASDAQ:CADX)

Cadence Pharmaceuticals, Inc. (Cadence) is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing products principally for use in the hospital setting. The Company has rights to one product, OFIRMEV (acetaminophen) injection, an intravenous (IV), formulation of acetaminophen. The Company in-licensed the United States, and Canadian rights to OFIRMEV from Bristol-Myers Squibb Company (BMS), which sells intravenous acetaminophen in Europe and other markets for the treatment of acute pain and fever under the brand name Perfalgan. In March 2014, Mallinckrodt Plc acquired Cadence Pharmaceuticals, Inc. In March 2014, Mallinckrodt Plc completed the acquisition of Cadence Pharmaceuticals.

Ad Manward Press

Can't believe it's happening again

We explain how this event works in full right here.

CADX Stock News Headlines

March 26, 2024 | tmcnet.com

Avicenna.AI secures FDA clearance for two healthcare AI solutions

March 1, 2024 | uk.finance.yahoo.com

Q4 2023 Xometry Inc Earnings Call

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

February 26, 2024 | finance.yahoo.com

Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria

January 29, 2024 | finanznachrichten.de

Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook

January 17, 2024 | finance.yahoo.com

Median Technologies Reports Excellent Results from Its Independent Verification Study

January 16, 2024 | markets.businessinsider.com

Blackford and Bot Image Announce Partnership to Enhance Prostate Cancer Care

October 19, 2023 | finance.yahoo.com

Median Technologies Reports 2023 Half-year Results and Business Indicators for the Third Quarter of 2023

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

October 16, 2023 | usatoday.com

Best unsecured credit cards for bad credit of October 2023

July 22, 2023 | usatoday.com

Are your credit card rewards in jeopardy under proposed legislation?

July 12, 2023 | finance.yahoo.com

Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan

June 15, 2023 | msn.com

How a good dog helped Daytona Beach veteran with PTSD to become a better husband, father

June 6, 2023 | msn.com

Walkers commits to one of biggest crisp factories in the world with £58m investment

June 5, 2023 | msn.com

Moneybagg Yo Balances Pain and Pleasure on ‘Hard To Love’

June 5, 2023 | msn.com

NFL teams that have never won a Super Bowl

May 17, 2023 | marketwatch.com

Computer Aided Diagnostics (CADx) Market Size and Trend Analysis 2023-2031 by Absolute Reports with [115 Pages] in Medical Devices Sector

April 24, 2023 | benzinga.com

Endoscopy Devices Market Will Attain USD 42.8 Bn Valuation by 2028 with CAGR of 3.8%: Exclusive Study by TMR

April 22, 2023 | marketwatch.com

Computer Aided Diagnostics (CADx) Market Report Offers CAGR Status and SWOT Analysis

April 21, 2023 | marketwatch.com

Sapphire Substrates Market Size and Share: Opportunities and Threats 2030

April 8, 2023 | msn.com

Breath of the Wild: Saas Ko'sah Shrine Guide (Hyrule Castle Shrine)

March 14, 2023 | msn.com

No, you’re not dreaming: Amazon’s offering unbelievable discounts on everything you need for a good night’s sleep

March 8, 2023 | marketwatch.com

Growth Analysis on Computer Aided Diagnostics (CADx) Market Size 2023-2028 with Market Dynamic and Trends | Research Report by Absolute Reports

March 3, 2023 | msn.com

Here's what the judge who sentenced Alex Murdaugh said

February 7, 2023 | msn.com

Teenager dies after being hit by snowplow at Laval shopping centre

January 24, 2023 | finance.yahoo.com

Computer Aided Diagnostics (CADx) Market Estimated to Grow at a CAGR of 13.3% from 2022 to 2030, Contrive Datum Insights

January 10, 2023 | msn.com

“Hanson” snow plow honors late Webster DOT driver

See More Headlines

Receive CADX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CADX) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Pharmaceuticals
Current Symbol: NASDAQ:CADX
CUSIP: 12738T10
CIK: 1333248
Web: www.cadencepharm.com
Phone: +1-858-4361400
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

CADX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (CADX) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (CADX) investors own include Albireo Pharma (ALBO), Agenus (AGEN), Aeterna Zentaris (AEZS), Authentidate (ADAT), Acasti Pharma (ACST), Axcelis Technologies (ACLS), Achillion Pharmaceuticals (ACHN), Atlantic Coast Financial (ACFC), Acer Therapeutics (ACER) and ARCA biopharma (ABIO).

This page (NASDAQ:CADX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(CADX) (CADX) Stock Price, News & Analysis

About (CADX) Stock (NASDAQ:CADX)

CADX Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

CADX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info